NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

NOVO.B.DK

237.55

-1.37%↓

GMAB.DK

1,801.5

+0.7%↑

HLUNB.DK

39.74

+0.15%↑

ZEAL.DK

295.5

+0.27%↑

AMBUB.DK

64.45

-1.9%↓

Search

Coloplast A-S (Class B)

Fechado

421.8 -3.03

Visão Geral

Variação de preço das ações

24h

Atual

Mín

420.5

Máximo

435

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.41

66.418

EPS

6.32

Rendimento de Dividendos

5.19

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.19%

2.36%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-21B

97B

Abertura anterior

424.83

Fecho anterior

421.8

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB: Higher Energy Prices to Raise Production, Consumer Costs

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Japan GDP Growth at 0.7% in 2026, 0.6% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects South Korea GDP Growth at 1.9% in 2026, 1.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Extent of Slowdown Hinges on Duration of MidEast Conflict, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects India GDP Growth at 6.9% in 2026, 7.3% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects China GDP Growth at 4.6% in 2026, 4.5% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Pojects Australia GDP Grrowth at 2.0% in 2026, 2.9% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

ADB Projects Taiwan GDP Growth at 7.6% in 2026, 4.0% in 2027

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Geopolitical Risks Make Asia's Economic Outlook Highly Uncertain, ADB Says

10 de abr. de 2026, 00:00 UTC

Notícias Principais

Asia Regional Growth Likely to Moderate in 2026-2027, ADB Says

9 de abr. de 2026, 23:44 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Talks -- Market Talk

9 de abr. de 2026, 23:34 UTC

Conversa de Mercado

Gold Edges Lower Amid Lingering Inflation Concerns -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Jefferies Upbeat on Australian Miners, But Recession a Key Risk -- Market Talk

9 de abr. de 2026, 23:14 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

9 de abr. de 2026, 23:07 UTC

Conversa de Mercado

Centaurus's Supply Deal with Glencore Supports Jaguar Development -- Market Talk

9 de abr. de 2026, 22:54 UTC

Conversa de Mercado

Transurban Lacks Appeal as Higher Fuel Prices Slow Traffic -- Market Talk

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'That Is Not the Agreement We Have!'

9 de abr. de 2026, 22:31 UTC

Notícias Principais

Trump on Truth Social: 'Iran Is Doing a Very Poor Job, Dishonorable Some Would Say, of Allowing Oil to Go Through the Strait of Hormuz'

9 de abr. de 2026, 20:57 UTC

Notícias Principais

U.S. Oil Prices Are Back Near $100 After Israel Keeps Up Air Strikes on Lebanon -- Barrons.com

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9 de abr. de 2026, 20:55 UTC

Ganhos

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Energy & Utilities Roundup: Market Talk

9 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

9 de abr. de 2026, 20:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Investment Positions Rowan to Continue Delivering Sustainable Data Center Capacity for World's Leading Technology Cos >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Blackstone Acquired Significant Minority Stake in Rowan Digital Infrastructure >BX

9 de abr. de 2026, 20:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Rowan Digital Infrastructure Announces Strategic Recapitalization

9 de abr. de 2026, 20:25 UTC

Aquisições, Fusões, Aquisições de Empresas

SBA Communications Stock Soars on Buyout Interest. What It Means for Tower Stocks. -- Barrons.com

9 de abr. de 2026, 20:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

9 de abr. de 2026, 19:30 UTC

Notícias Principais

How Digital Currencies Have Helped Iran -- WSJ

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat